X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sun Pharma with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ORCHID PHARMA LTD - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA ORCHID PHARMA LTD SUN PHARMA/
ORCHID PHARMA LTD
 
P/E (TTM) x 32.8 -0.2 - View Chart
P/BV x 2.7 0.2 1,808.7% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 SUN PHARMA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    SUN PHARMA
Mar-18
ORCHID PHARMA LTD
Sep-13
SUN PHARMA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs701194 361.1%   
Low Rs43335 1,237.7%   
Sales per share (Unadj.) Rs110.4276.5 39.9%  
Earnings per share (Unadj.) Rs11.0-79.2 -13.9%  
Cash flow per share (Unadj.) Rs17.2-43.5 -39.7%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs158.853.9 294.4%  
Shares outstanding (eoy) m2,399.2670.45 3,405.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x5.10.4 1,239.7%   
Avg P/E ratio x51.6-1.4 -3,572.2%  
P/CF ratio (eoy) x32.9-2.6 -1,248.5%  
Price / Book Value ratio x3.62.1 168.2%  
Dividend payout %18.20-   
Avg Mkt Cap Rs m1,360,0218,067 16,860.1%   
No. of employees `00017.82.8 635.3%   
Total wages/salary Rs m53,6712,527 2,123.9%   
Avg. sales/employee Rs Th14,890.96,956.1 214.1%   
Avg. wages/employee Rs Th3,017.1902.5 334.3%   
Avg. net profit/employee Rs Th1,480.6-1,993.0 -74.3%   
INCOME DATA
Net Sales Rs m264,89519,477 1,360.0%  
Other income Rs m8,388407 2,059.8%   
Total revenues Rs m273,28219,884 1,374.4%   
Gross profit Rs m56,0811,103 5,086.3%  
Depreciation Rs m14,9982,519 595.4%   
Interest Rs m5,1765,227 99.0%   
Profit before tax Rs m44,295-6,236 -710.3%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-9,505511 -1,860.1%   
Tax Rs m8,452-125 -6,750.7%   
Profit after tax Rs m26,338-5,580 -472.0%  
Gross profit margin %21.25.7 374.0%  
Effective tax rate %19.12.0 950.4%   
Net profit margin %9.9-28.7 -34.7%  
BALANCE SHEET DATA
Current assets Rs m316,35911,014 2,872.3%   
Current liabilities Rs m198,64332,060 619.6%   
Net working cap to sales %44.4-108.1 -41.1%  
Current ratio x1.60.3 463.6%  
Inventory Days Days9595 99.9%  
Debtors Days Days10834 320.9%  
Net fixed assets Rs m213,17829,440 724.1%   
Share capital Rs m2,399705 340.6%   
"Free" reserves Rs m378,6062,043 18,535.5%   
Net worth Rs m381,0063,800 10,026.7%   
Long term debt Rs m17,7219,018 196.5%   
Total assets Rs m643,02846,510 1,382.5%  
Interest coverage x9.6-0.2 -4,949.4%   
Debt to equity ratio x02.4 2.0%  
Sales to assets ratio x0.40.4 98.4%   
Return on assets %4.9-0.8 -644.8%  
Return on equity %6.9-146.9 -4.7%  
Return on capital %10.0-3.7 -268.4%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m40,8167,513 543.3%   
Fx outflow Rs m30,1435,649 533.6%   
Net fx Rs m10,6731,865 572.4%   
CASH FLOW
From Operations Rs m39,0721,682 2,323.3%  
From Investments Rs m-33,708-9,860 341.9%  
From Financial Activity Rs m-15,3936,644 -231.7%  
Net Cashflow Rs m-7,359-1,535 479.4%  

Share Holding

Indian Promoters % 63.7 32.3 197.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 4.6 111.5%  
FIIs % 23.0 3.3 697.0%  
ADR/GDR % 0.0 4.6 -  
Free float % 8.3 55.3 15.0%  
Shareholders   133,026 84,811 156.8%  
Pledged promoter(s) holding % 0.5 54.9 1.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   FDC LTD.  UNICHEM LAB  CIPLA  AJANTA PHARMA  ALEMBIC LTD  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Higher; FMCG and Banking Stocks Gain(12:30 pm)

Stock markets in India are presently trading higher. The BSE Sensex is trading up by 104 points and the NSE Nifty is trading up by 32 points.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

A One Stock Crorepati(Profit Hunter)

Jul 4, 2019

Do you wish you could become a crorepati in the stock market? Read on...

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 17, 2019 02:19 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS